Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Gross Profit (2022 - 2025)

Historic Gross Profit for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$363000.0.

  • Envoy Medical's Gross Profit fell 739.64% to -$363000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year increase of 117.16%. This contributed to the annual value of -$1.5 million for FY2024, which is 1177.78% down from last year.
  • As of Q3 2025, Envoy Medical's Gross Profit stood at -$363000.0, which was down 739.64% from -$283000.0 recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Gross Profit ranged from a high of -$49000.0 in Q3 2022 and a low of -$518000.0 during Q4 2022
  • For the 4-year period, Envoy Medical's Gross Profit averaged around -$337230.8, with its median value being -$320000.0 (2023).
  • As far as peak fluctuations go, Envoy Medical's Gross Profit crashed by 55102.04% in 2023, and later surged by 3403.26% in 2025.
  • Quarter analysis of 4 years shows Envoy Medical's Gross Profit stood at -$518000.0 in 2022, then increased by 19.31% to -$418000.0 in 2023, then decreased by 13.88% to -$476000.0 in 2024, then grew by 23.74% to -$363000.0 in 2025.
  • Its last three reported values are -$363000.0 in Q3 2025, -$283000.0 for Q2 2025, and -$312000.0 during Q1 2025.